Skip to main content
Jasmeer Chhatwal, MD, Neurology, Boston, MA

JasmeerPreetChhatwalMDPhD

Neurology • Boston, MA

Clinical Fellow in Neurology, Massachusetts General Hospital

Join to view full profile

Dr. Chhatwal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chhatwal's full profile

Already have an account?

  • Office

    55 Fruit St - Neurology / Memory Disorders
    Wacc 715, Massachusetts General Hospital
    Boston, MA 02114
    Phone+1 617-726-1728

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2009 - 2012
  • New York Downtown Hospital
    New York Downtown HospitalInternship, Internal Medicine, 2008 - 2009
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2008

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2026
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Journal Articles

  • Nonlinear Distributional Mapping (NoDiM) for Harmonization Across Amyloid-PET Radiotracers☆  
    Jasmeer P Chhatwal, Reisa A Sperling, Keith A Johnson, ScienceDirect
  • Anticholinergic Amnesia Is Mediated by Alterations in Human Network Connectivity Architecture  
    Reisa A Sperling, Brendon P Boot, Keith A Johnson, Dorene Rentz, Jasmeer P Chhatwal, Cerebral Cortex

Authored Content

  • Sex, Amyloid, and APOE ε4 and Risk of Cognitive Decline in Preclinical Alzheimer's Disease: Findings from Three Well-Characterized CohortsMay 2018

Press Mentions

  • In Familial AD, Amyloid-PET Varies by Mutation Type; CSF Aβ42 Doesn't
    In Familial AD, Amyloid-PET Varies by Mutation Type; CSF Aβ42 Doesn'tFebruary 11th, 2022
  • Plasma NT1: This Tau Snippet Predicts Cognitive Decline in Alzheimer’s
    Plasma NT1: This Tau Snippet Predicts Cognitive Decline in Alzheimer’sDecember 4th, 2020
  • Plasma NT1: Does This Tau Snippet Predict Cognitive Decline in Alzheimer’s?
    Plasma NT1: Does This Tau Snippet Predict Cognitive Decline in Alzheimer’s?December 4th, 2020
  • Join now to see all

Grant Support

  • Plasma tau and neurodegenerative markers as predictors of rate of AD progressionMASSACHUSETTS GENERAL HOSPITAL2021–2026
  • Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD BiomarkersBRIGHAM AND WOMEN'S HOSPITAL2022–2025
  • Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's DiseaseMASSACHUSETTS GENERAL HOSPITAL2019–2025
  • Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's DiseaseMASSACHUSETTS GENERAL HOSPITAL2019–2025

Other Languages

  • Punjabi

Dr. Jasmeer Chhatwal, Dr. Jasmeer Chhatwal, MD, Dr. J Chhatwal, Dr. Jasmeer Preet Chhatwal